Chantix

The new stop-smoking aid, varenicline, is due to be launched in the UK on 5 December. It will be sold under the brand name Champix.

ASH has produced guidance for health professionals on this new drug and this is now available on the ASH website at:
www.ash.org.uk/html/cessation/ASHVareniclineguidance.pdf

The ASH guidance has been produced by Dr Ann McNeill and Dr Martin Raw, the authors of the original ‘Thorax’ smoking cessation guidelines. It has the backing of the Department of Health and should be viewed as interim advice until NICE issues its own guidance next Spring.

I trust you will find the guidance self-explanatory but please do get in touch if you have any specific queries that are not covered in the document.

Please note that we will be press releasing the guidance to the media on 5th December to coincide with the launch of Champix. In the meantime, we would be happy for you to circulate this guidance among smoking cessation colleagues – in fact we would like you to do so – but please do not send to the media before 5th December.
Regards
Amanda SandfordResearch ManagerASH102 Clifton StreetLONDONEC2A 4HWt 020 7739 5902f 020 7613 0531

Smoking and human papillomavirus

Teaching Brief® - MedPage Today: "Review
STOCKHOLM, Nov. 17 -- Smoking and human papillomavirus (HPV) may work together to increase the risk of cervical cancer in situ, according to researchers here.
In a case-control study, smokers infected with HPV-16, the most prevalent of the oncogenic types, had 14 times the risk of progressing to cancer than did smokers who weren't carrying the virus, found Anthony Gunnell, a doctoral candidate at the Karolinska Institute here.
These HPV-16-positive smokers also had more than double the risk of non-smokers with an HPV-16 infection, Gunning and colleagues reported in the November issue of Cancer Epidemiology, Biomarkers & Prevention. "

Smokeless Tobacco Quitting Tips

Smokeless Tobacco Quitting Tips: "Today oral tobacco lesions (leukoplakia) are being detected in about 1.5% of students, projected at 300,000 nationally, with substantially greater incidence among snuff than chewing tobacco users. But in only 26 per 100,000 cases each year do the white spots actually develop into oral cancer. That means that among the 5 million U.S. smokeless tobacco users, at most there are 1,300 oral cancer nightmares each year, nightmares which kill about half within five years.
Looking at such statistics, the rationalizing snuff or chewing tobacco user probably won't put death from oral cancer at the top of their list of concerns. Likewise, a 2.23 greater risk of sudden heart attack (four times greater for chewers who also smoke) may not be sufficient to motivate quitting without first experiencing stabbing type chest pains. Even then, getting serious about quitting often requires a doctor's 'quit or drop-dead' ultimatum. But what oral nicotine users would be wise to note are growing concerns that long-term nicotine use may actually be eating away and destroying their brain.
An increasing number of experiments show that long-term nicotine use reduces the number of brain neurons, increases the signs of cell death in brain tissue and impairs working memory. A September 2006 study used MRIs to examine the brains of smokers. It found significantly less brain grey matter volume and density, with loss of grey matter proportional to the number of years smoked."

Lançamento de livros

É com enorme satisfação que convidamos a todos para o coquetel de lançamento dos livros

"Atualização no Tratamento do Tabagismo",
organizado por Analice Gigliotti e Sabrina Presman

&

"Dependência, Compulsão e Impulsividade "
organizado por Analice Gigliotti e Angela Guimaraes


Dia: 24 de novembro de 2006
Hora: 19:30 hs
Local: Colégio Brasileiro de Cirurgiões
(Rua Visconde SIlva, 52 - Rio de Janeiro)

Esperamos você lá!

Analice Gigliotti, Angela Guimarães e Sabrina Presman

* Caso você não possa comparecer e deseje adquirir o livro por favor mande um e-mail para clif@email.iis.com.br

classic industry denial clip

De: Prof. Simon Chapman [mailto:chapman@globalink.org] Enviada em: quinta-feira, 9 de novembro de 2006 04:54Para: General MessagesAssunto: classic industry denial clip

I have posted a classic industry health damage denial film clip at http://tobacco.health.usyd.edu.au/...It may be useful to many of you to download & use to succinctly illustrate to audiences the sort of risk awareness diet fed by the industry to the community for decades. This one is from Australia in 1984, meaning that a 20 year old smoker who saw it then, believed it (that was the communicative intent)and took comfort & reassurance would be only 44 today. Don't let anyone dismiss this period of wholesale deceit as being irrelevant today.Simon Chapman

Bladder cancer early smoking link

BBC NEWS Health Bladder cancer early smoking link: "Researchers funded by Cancer Research UK looked at data on almost 430,000 people across Europe.
They found people who smoked before the age of 15 were three times more likely to get bladder cancer later in life.
Those exposed to second-hand smoke in childhood were almost 40% more likely to develop bladder cancer.
The disease is the fourth most common cancer among men and kills more than 4,800 people in the UK each year.
The research was published in the International Journal of Cancer. /.../"